Noventra Pharma Tirzepatide Research Compound peptide Pen 30mg

Weight Management • Appetite Control • Blood Sugar Support

 Pharma Tirzepatide 30mg is a GLP-1 agonist proven for weight loss by promoting appetite suppression, fat loss, and metabolic support. It activates GLP-1 receptors to trigger insulin release and regulate glucose, slows gastric emptying to increase satiety and reduce calorie intake, and enhances metabolism by improving insulin sensitivity and promoting fat oxidation for sustained weight loss.

Tirzepatide, also known as Mounjaro, is an innovative medication developed for type 2 diabetes mellitus (T2DM). It acts as a dual agonist for glucose-dependent insulinotropic peptide (GIP) and GLP-1 receptors, both of which regulate blood sugar and metabolism. By stimulating insulin secretion, reducing glucagon release, slowing digestion, and reducing food intake, tirzepatide offers comprehensive glycemic control.

Disclaimer

This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.

Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.